Item 12: Adoption of the report of the Commission on its sixty-seventh session CND Chair (Ghana): Excellencies, distinguished representatives, ladies and gentlemen. Good afternoon. We shall now turn our attention to item 12, adoption of the report of the Commission on its 67th session. We will proceed with the adoption of the draft resolutions. Before doing …
Resolution L.4. Chair: We had a successful morning and hopefully we will be able to continue in this way. I would like to open this afternoon with our resolution L4 of Belgium. The title is being negotiated in informals but I will give the floor to Belgium to inform us of developments Belgium: Thank you …
UN Web TV recording ;Bangladesh/Chair: Discuss the work done around the globe to implement drug control commitments – identify progress, identify challenges. This will consist of a panel of interventions followed by interactive discussions. Mexico/Co-Chair: Delegations wishing to take the floor can raise their panels to nominate themselves. Please bear with me if I call …
UN Web TV recording Opening of the 67th session of the Commission on Narcotic DrugsOutcome Document: High-level Declaration by the Commission on Narcotic Drugs on the 2024 midterm review, following up to the 2019 Ministerial DeclarationChair: Welcome. Inform you that for the opening session of the HLS, there’ll be a video transmission of the …
Chair: First and foremost, I would like to welcome you to the first intersessional meeting of a CND during this ssession. To start, I want to ensure that we’re aligned on the significant matters we’ve encountered, particularly regarding the outcome document. First of all though, the floor is the Secretariat’s. Secretariat: Thank you, Mr. Chair. Good …
Chair: I am grateful for your cooperation earlier this year. We had previously discussed the Resolution, outlining the review process, and collectively decided to convene before he regular committee session. The high-level segment is scheduled for March 14th and 15th, dedicated to assessing the implementation of international drug policy commitments. During this segment, we aim …